Triatomic Capital

Triatomic Capital invests across a diverse range of sectors, including AI technologies, biotech, energy, healthcare, fintech, climate, frontier technologies, commerce, consumer products, and industrial applications. The firm emphasizes next-generation computing, automation of chip design, blockchain technology, new materials, engineered biology, and innovative energy solutions such as next-generation fission and fusion.

Investment stages are flexible, targeting both early and growth stages. Triatomic Capital seeks to invest in companies that align with its thesis of applied AI as an enabling layer for century-defining physical-world and life-science problems. The firm looks for founders who demonstrate a strong vision and capability to navigate complex challenges in their respective fields.

Triatomic Capital's portfolio includes notable companies that exemplify its investment strategy:

• Chalk.ai - A machine learning feature store that enhances data infrastructure.
• Chemify.io - Focuses on AI-driven drug synthesis, revolutionizing chemistry.
• Coworker.ai - An AI workforce platform designed to optimize labor.
• D-Matrix - Develops in-memory compute chips for AI inference, improving processing efficiency.
• Edison Scientific - Specializes in nuclear energy solutions, contributing to sustainable energy.
• Efficient.computer - Provides energy-efficient AI hardware, addressing power consumption challenges.
• Elegant Bio - Engages in biotech and protein engineering, advancing biological research.
• Gimlet Labs - Offers AI video analytics infrastructure for enhanced media processing.
• Ipronics - Works on programmable photonics, pushing the boundaries of optical technology.
• Lyten - Develops lithium-sulfur batteries and graphene materials, focusing on energy storage.
• Manifold Bio - Specializes in protein library screening, aiding drug discovery.
• Matx - Creates custom AI accelerators, enhancing computational capabilities.

Jeff Huber - General Partner. Formerly a Senior Vice President of Engineering at Google, Huber co-founded Color Health, focusing on genomics and healthcare technology.

Steve Hochberg - General Partner. Hochberg brings extensive experience in venture capital and technology investments, contributing to the firm's strategic direction.

Peter Zhou - General Partner. Zhou has a strong background in technology and investment, enhancing the firm's analytical capabilities.

Anh Wilson - Head of Business Development and Investor Relations. Wilson plays a key role in managing relationships with portfolio companies and investors.

Willem van den Bosch - Principal. Van den Bosch focuses on sourcing and evaluating new investment opportunities.

Benjamin Li - Head of APAC. Li oversees the firm's activities and investments in the Asia-Pacific region, expanding Triatomic's global reach.

Startups looking to pitch to Triatomic Capital should do so through their website at triatomic.ai. It is important to include a comprehensive deck that outlines the business model, market opportunity, and technology details. The firm appreciates clear and concise presentations that highlight the startup's unique value proposition.

Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.

As of October 2023, Triatomic Capital has made significant strides in its investment activities. The firm has added several innovative companies to its portfolio, focusing on AI applications and advanced energy solutions. Recent investments include companies developing real-time data platforms for AI and solutions for digitizing chemistry in drug discovery.

Triatomic Capital continues to explore opportunities that align with its investment thesis, particularly in sectors that drive digitization and automation. The firm remains committed to supporting transformative technologies that are expected to define the century.